Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Maryland Society for Rheumatic Diseases Prepares for New Meeting Format, Eyes Advocacy Opportunities

Linda Childers  |  October 6, 2022

Bansari Gujar, MD, a rheumatologist with Rheumatology Associates of Baltimore, has attended annual meetings of the Maryland Society for the Rheumatic Diseases (MSRD) since she was a fellow at the University of Maryland Medical System. This year, Dr. Gujar will oversee her first annual meeting as the society’s president.

Dr. Gujar

“For the past two years, we’ve held our continuing medical education (CME) meetings virtually,” says Dr. Gujar, who became president in January. “We’re launching into a new annual meeting format and look forward to welcoming members back in person. There’s a real sense of community and camaraderie when we meet in person, and meetings such as these will hopefully provide opportunities to engage with and support our colleagues and expand our professional networks.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

This year’s annual meeting, Oct. 14–15 at the Hyatt Regency Baltimore Inner Harbor, will feature notable speakers and a variety of topics of interest to rheumatologists, nurse practitioners and physician assistants. Among the subjects to be covered are COVID-19 and autoimmunity, pregnancy and rheumatic diseases, giant cell arteritis, systemic sclerosis, novel therapeutics for lupus and updates and difficult cases in myositis.

“Our meeting is open to all rheumatology professionals,” Dr. Gujar says. “The majority of attendees come from Maryland, but we also hope to have participants from Delaware, Philadelphia, Virginia and Washington, D.C.” For more information, visit www.msrdmd.net.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

As the new president, Dr. Gujar hopes to expand the society’s advocacy efforts.

“Our goal is to become involved in legislative discussions impacting rheumatologists and our patients in Maryland. It’s important that we advocate at the state and federal level for legislation that supports patient care and ensures our patients have access to the medications they need at an affordable cost,” Dr. Gujar says. “This includes becoming more involved in ACR advocacy efforts that address issues that impact patient care significantly, such as step therapy, non-medical switching and increasing oversight on pharmacy benefit managers.”

Because physical therapists and other professionals are an important part of the rheumatology team, Dr. Gujar hopes to expand outreach to invite these groups to join MSRD and offer them CMEs.

MSRD also engages with clinical fellows at the University of Maryland and Johns Hopkins University, both in Baltimore, by offering grants that allow them to attend the annual conference at no charge.

A Total Cost of Care Model

Dr. Christopher-Stine

Page: 1 2 | Single Page
Share: 

Filed under:Professional Topics Tagged with:Bansari GujarLisa Christopher-Stinestate society

Related Articles
    Tashatuvango / shutterstock.com

    Myositis-Specific Antibodies Identified

    January 16, 2020

    The idiopathic inflammatory myopathies (IIM) encompass eight categories: 1) dermatomyositis (DM) in adults, 2) juvenile dermatomyositis, 3) amyopathic DM, 4) cancer-associated DM, 5) polymyositis, 6) immune-mediated necrotizing myopathy, 7) inclusion body myositis, and 8) overlap myositis.1 These categories help classify the myopathies based on clinical and histologic features. The incidence of IIM is estimated at…

    Autoantibodies in Autoimmune Myopathy

    Autoantibodies in Autoimmune Myopathy

    September 18, 2017

    In recent years, scientists and clinicians have learned a great deal about autoantibodies occurring in idiopathic inflammatory myopathies (IIMs). These new discoveries have reshaped our understanding of distinct clinical pheno­types in IIMs. Scientists continue to learn more about how these auto­antibodies shape pathophysiology, diagnosis, disease monitoring, prognosis and optimum treatment. Moving forward, these autoantibodies will…

    The Care & Treatment of Myositis: Creatinine Kinase Level Isn’t Gospel & Other Recommendations

    January 28, 2020

    During a session at the 2019 ACR/ARP Annual Meeting, Lisa Christopher-Stine, MD, MPH, provided valuable recommendations and practical insights into the care and treatment of myositis patients…

    New Tools for Myositis Diagnosis, Classification & Management

    April 15, 2019

    CHICAGO—At Hot Topics in Myositis, a session at the 2018 ACR/ARHP Annual Meeting, three experts discussed new classification criteria for idiopathic inflammatory myopathies (IIM) and offered practical primers on overlap myositis conditions and inclusion body myositis (IBM). New Myositis Classification Criteria After a 10-year development process, the new EULAR/ACR Classification Criteria for Adult and Juvenile…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences